Passage Bio, Inc. (PASG) Dividend History

Passage Bio, Inc. is a biopharmaceutical company focused on developing gene therapies for rare and devastating neurological and genetic disorders. Established with the goal of transforming patient lives, Passage Bio leverages its proprietary platform to discover and develop treatments targeting novel genetic and neurological conditions.

One Commerce Square, Philadelphia, PA, 19103
Phone: (267) 866-0312
Website: https://www.passagebio.com

Dividend History

Passage Bio, Inc. currently does not pay dividends

Company News

  • The report provides a comprehensive analysis of the Adeno-Associated Virus (AAV) Vectors in Gene Therapy pipeline, highlighting the potential of this technology to revolutionize the treatment of genetic disorders. It examines the challenges in scalable production and safety, as well as the industry's focus on optimizing vectors for improved safety, specificity, and efficiency.

    GlobeNewswire Inc.
    Featured Companies: ADVM BIIB FDMT JNJ MGTX RARE RCKT RGNX SRPT TNYA
  • The heavy selling pressure might have exhausted for Passage Bio (PASG) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

    Zacks Investment Research
  • Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of third-quarter results. BlackBerry reported quarterly earnings of 1 cent per share which exceeded the Street's estimate of losses of 3 cents per share, according to Benzinga Pro. The company also said it sees fourth-quarter revenue of $150 million to $159 million. BlackBerry shares fell 5.4% to $3.88 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers Infrared Cameras Holdings Inc (NASDAQ: MSAI) rose 213% to $8.20 in pre-market trading after falling over 61% on Wednesday. Mobile Global Esports Inc.(NASDAQ: MGAM) gained 53.4% to $0.4294 in pre-market trading after falling 4% on Wednesday. Mesoblast Limited (NASDAQ: MESO) shares gained 32.1% to $1.40 in pre-market trading. Mesoblast recently reported placement and accelerated non-renounceable entitlement offer to raise up to A$97 million. ParaZero Technologies Ltd. (NASDAQ: PRZO) shares surged 30.9% to $1.61 in pre-market trading. ParaZero shares jumped over 75% on Wednesday after the company announced ...

    Benzinga
    Featured Companies: ACON BB INM INO MSAI MU PRZO SXTP
Page data last updated 07/23/2025 17:32:47 UTC